{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T01:08:00Z","timestamp":1713488880780},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,18]]},"DOI":"10.7759\/cureus.58507","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T07:24:05Z","timestamp":1713425045000},"source":"Crossref","is-referenced-by-count":0,"title":["Sight-Threatening Unilateral Posterior Scleritis With Positive Atypical p-ANCA As Early Manifestation of Lupus Spectrum Disease"],"prefix":"10.7759","author":[{"given":"Li Lian","family":"Chew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"See","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chai Lee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelina","family":"Oli Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajunisah","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazirah","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2016.1136190","article-title":"Scleritis","volume":"24","author":"Cunningham ET Jr","year":"2016","unstructured":"Cunningham ET Jr, McCluskey P, Pavesio C, Wakefield D, Zierhut M. Scleritis. Ocul Immunol Inflamm. 2016, 24:2-5. 10.3109\/09273948.2016.1136190","journal-title":"Ocul Immunol Inflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1991.tb01804.x","article-title":"Antineutrophil cytoplasmic antibody in uveitis and scleritis","volume":"19","author":"Mills RAD","year":"1991","unstructured":"Mills RAD, Weeramanthri TS, Hollingsworth PN, Cooper RL. Antineutrophil cytoplasmic antibody in uveitis and scleritis. Aust N Z J Ophthalmol. 1991, 19:71-73. 10.1111\/j.1442-9071.1991.tb01804.x","journal-title":"Aust N Z J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.5.651","article-title":"Antineutrophil cytoplasmic antibody-associated active scleritis","volume":"126","author":"Hoang LT","year":"2008","unstructured":"Hoang LT, Lim LL, Vaillant B, Choi D, Rosenbaum JT. Antineutrophil cytoplasmic antibody-associated active scleritis. Arch Ophthalmol. 2008, 126:651-655. 10.1001\/archopht.126.5.651","journal-title":"Arch Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(95)30970-0","article-title":"Scleritis associated with systemic vasculitic diseases","volume":"102","author":"Sainz de la Maza M","year":"1995","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995, 102:687-692. 10.1016\/s0161-6420(95)30970-0","journal-title":"Ophthalmology"},{"key":"ref5","article-title":"Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations","volume":"59","author":"Fauzi AR","year":"2004","unstructured":"Fauzi AR, Kong NC, Chua MK, Jeyabalan V, Idris MN, Azizah R. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med J Malaysia. 2004, 59:372-377.","journal-title":"Med J Malaysia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23894","article-title":"Incomplete systemic lupus erythematosus: what remains after application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria?","volume":"72","author":"Lambers WM","year":"2020","unstructured":"Lambers WM, Westra J, Jonkman MF, Bootsma H, de Leeuw K. Incomplete systemic lupus erythematosus: what remains after application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria?. Arthritis Care Res (Hoboken). 2020, 72:607-614. 10.1002\/acr.23894","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_777_18","article-title":"Antineutrophil cytoplasmic antibody-positive scleritis: clinical profile of patients from a tuberculosis-endemic region","volume":"66","author":"Majumder PD","year":"2018","unstructured":"Majumder PD, Sudharshan S, George AE, Ganesh SK, Biswas J. Antineutrophil cytoplasmic antibody-positive scleritis: clinical profile of patients from a tuberculosis-endemic region. Indian J Ophthalmol. 2018, 66:1587-1591. 10.4103\/ijo.IJO_777_18","journal-title":"Indian J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1502787","article-title":"Atypical perinuclear anti-neutrophil cytoplasmic antibodies in ocular inflammatory diseases","volume":"27","author":"Ebrahimiadib N","year":"2019","unstructured":"Ebrahimiadib N, Ma L, Modjtahedi BS, et al.. Atypical perinuclear anti-neutrophil cytoplasmic antibodies in ocular inflammatory diseases. Ocul Immunol Inflamm. 2019, 27:937-941. 10.1080\/09273948.2018.1502787","journal-title":"Ocul Immunol Inflamm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-006-0408-z","article-title":"Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: case series and literature review","volume":"51","author":"Matsuo T","year":"2007","unstructured":"Matsuo T. Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: case series and literature review. Jpn J Ophthalmol. 2007, 51:131-138. 10.1007\/s10384-006-0408-z","journal-title":"Jpn J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01649.x","article-title":"Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy","volume":"126","author":"Terjung B","year":"2001","unstructured":"Terjung B, Worman HJ, Herzog V, Sauerbruch T, Spengler U. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin Exp Immunol. 2001, 126:37-46. 10.1046\/j.1365-2249.2001.01649.x","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.057003846.x","article-title":"Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features","volume":"57","author":"Savige J","year":"2000","unstructured":"Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 2000, 57:846-862. 10.1046\/j.1523-1755.2000.057003846.x","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000856","article-title":"Lupus spectrum ambiguity has long-term negative implications for patients","volume":"10","author":"Bruce IN","year":"2023","unstructured":"Bruce IN, Buie J, Bloch L, et al.. Lupus spectrum ambiguity has long-term negative implications for patients. Lupus Sci Med. 2023, 10:e000856. 10.1136\/lupus-2022-000856","journal-title":"Lupus Sci Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/290898","article-title":"Ocular manifestations of systemic lupus erythematosus: a review of the literature","volume":"2012","author":"Palejwala NV","year":"2012","unstructured":"Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012, 2012:290898. 10.1155\/2012\/290898","journal-title":"Autoimmune Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.7.625","article-title":"Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus","volume":"35","author":"Spronk PE","year":"1996","unstructured":"Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, Kallenberg CG. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol. 1996, 35:625-631. 10.1093\/rheumatology\/35.7.625","journal-title":"Br J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2016.02.001","article-title":"Ocular findings in systemic lupus erythematosus","volume":"30","author":"Shoughy SS","year":"2016","unstructured":"Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol. 2016, 30:117-121. 10.1016\/j.sjopt.2016.02.001","journal-title":"Saudi J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226632","article-title":"Treatment of various ocular manifestation of systemic lupus erythematosus with therapeutic plasma exchange","volume":"11","author":"Lee JH","year":"2022","unstructured":"Lee JH, Jeon HW, Moon SJ, Lee MY. Treatment of various ocular manifestation of systemic lupus erythematosus with therapeutic plasma exchange. J Clin Med. 2022, 11:6632. 10.3390\/jcm11226632","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-011-1922-3","article-title":"Use of hydroxychloroquine in corticodependent and recurrent scleritis","volume":"251","author":"Maschi C","year":"2013","unstructured":"Maschi C, Tieuli\u00e9 N, Gastaud P, Baillif S. Use of hydroxychloroquine in corticodependent and recurrent scleritis. Graefes Arch Clin Exp Ophthalmol. 2013, 251:989-990. 10.1007\/s00417-011-1922-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247775-sight-threatening-unilateral-posterior-scleritis-with-positive-atypical-p-anca-as-early-manifestation-of-lupus-spectrum-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T07:24:08Z","timestamp":1713425048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247775-sight-threatening-unilateral-posterior-scleritis-with-positive-atypical-p-anca-as-early-manifestation-of-lupus-spectrum-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.58507","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,18]]}}}